Hunan Nucien Pharmaceutical Co., Ltd. (SHA:688189)

Market Cap	1.70B -47.6%
Revenue (ttm)	127.35M -18.3%
Net Income	-142.12M
EPS	-0.52
Shares Out	272.11M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,294,138
Open	6.52
Previous Close	6.53
Day's Range	6.16 - 6.55
52-Week Range	5.47 - 18.78
Beta	0.30
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 31, 2026

About SHA:688189

Hunan Nucien Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research and development, production, and sale of chemical drugs in China. The company also focuses on the research, development, production, and sales of antiviral drugs, including influenza and infectious disease prevention and treatment drugs, as well as medicines for anti-influenza, malignant tumors, cardiovascular, antibiotics, antipyretics, pain relief, diabetes, analgesic, cerebrovascular, respiratory, and other pharmaceutical fields. Hunan Nucien Pharmaceuti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2006
• Employees: 302
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688189

Financial Performance

In 2025, SHA:688189's revenue was 141.93 million, a decrease of -43.62% compared to the previous year's 251.72 million. Losses were -136.90 million, -60.49% less than in 2024.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 30, 2026

Data Sources Report a data error